Abstract
C16H16ClNO, monoclinic, P21/n (no. 14), a = 9.2566 Å, b = 9.2270(7) Å, c = 17.2231(14) Å, β = 103.745(8)°, V = 1428.9(2) Å3, Z = 4, R gt (F) = 0.0655, wR ref (F 2) = 0.2113, T = 293 K.
The crystal structure is shown in the figure above. Tables 1 and 2 contain details of the measurement method and a list of atoms including atomic coordinates and displacement parameters (Table 3).

Data collection and handling.
Crystal: | Colourless needle |
Size: | 0.20 × 0.19 × 0.18 mm |
Wavelength: | Mo Kα radiation (0.71073 Å) |
μ: | 0.26 mm−1 |
Diffractometer, scan mode: | New Gemini, ω |
θ max, completeness: | 26.1°, >99 % |
N(hkl)measured, N(hkl)unique, R int: | 5452, 2747, 0.056 |
Criterion for I obs, N(hkl)gt: | I obs > 2σ(I obs), 2016 |
N(param)refined: | 174 |
Programs: | Shelx 1 , 2 , Olex2 3 |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
Atom | x | y | z | U iso */U eq |
---|---|---|---|---|
Cl4 | 1.29708 (10) | 0.84145 (12) | 0.49615 (6) | 0.0744 (4) |
O2 | 0.9871 (3) | 0.8763 (3) | 0.41374 (13) | 0.0681 (7) |
N4 | 0.8798 (3) | 0.7564 (2) | 0.49972 (13) | 0.0464 (5) |
C6 | 1.1470 (3) | 0.8030 (3) | 0.53936 (16) | 0.0506 (6) |
H6A | 1.1579 | 0.7058 | 0.5614 | 0.061* |
H6B | 1.1481 | 0.8703 | 0.5828 | 0.061* |
C12 | 0.9055 (3) | 0.7800 (3) | 0.64340 (16) | 0.0481 (6) |
H12 | 0.9127 | 0.8800 | 0.6387 | 0.058* |
C15 | 0.6784 (3) | 0.6403 (3) | 0.39544 (15) | 0.0462 (6) |
C17 | 0.8885 (3) | 0.6922 (3) | 0.57668 (15) | 0.0431 (6) |
C19 | 0.8737 (3) | 0.5441 (3) | 0.58417 (16) | 0.0500 (6) |
H19 | 0.8614 | 0.4848 | 0.5394 | 0.060* |
C23 | 0.9117 (3) | 0.7176 (3) | 0.71729 (17) | 0.0531 (7) |
H23 | 0.9259 | 0.7766 | 0.7622 | 0.064* |
C30 | 0.5576 (3) | 0.5591 (4) | 0.40520 (16) | 0.0545 (7) |
H30 | 0.5099 | 0.5838 | 0.4452 | 0.065* |
C32 | 0.8973 (3) | 0.5702 (4) | 0.72574 (16) | 0.0512 (7) |
C34 | 0.9989 (3) | 0.8150 (3) | 0.47790 (16) | 0.0498 (6) |
C35 | 0.7483 (3) | 0.6011 (4) | 0.33546 (18) | 0.0554 (7) |
H35 | 0.8294 | 0.6542 | 0.3281 | 0.066* |
C40 | 0.8771 (3) | 0.4840 (3) | 0.65829 (17) | 0.0530 (7) |
H40 | 0.8657 | 0.3845 | 0.6628 | 0.064* |
C41 | 0.7304 (3) | 0.7707 (3) | 0.44685 (18) | 0.0545 (7) |
H41A | 0.7296 | 0.8540 | 0.4124 | 0.065* |
H41B | 0.6602 | 0.7896 | 0.4794 | 0.065* |
C55 | 0.6977 (4) | 0.4840 (4) | 0.28679 (19) | 0.0672 (9) |
H55 | 0.7454 | 0.4578 | 0.2471 | 0.081* |
C59 | 0.5769 (4) | 0.4057 (4) | 0.2968 (2) | 0.0675 (9) |
H59 | 0.5422 | 0.3277 | 0.2633 | 0.081* |
C62 | 0.9030 (5) | 0.5037 (5) | 0.8068 (2) | 0.0816 (11) |
H62A | 1.0029 | 0.5081 | 0.8390 | 0.122* |
H62B | 0.8714 | 0.4044 | 0.8001 | 0.122* |
H62C | 0.8381 | 0.5564 | 0.8326 | 0.122* |
C67 | 0.5075 (4) | 0.4424 (4) | 0.3562 (2) | 0.0653 (8) |
H67 | 0.4268 | 0.3885 | 0.3633 | 0.078* |
Fractional atomic coordinates and displacement parameters (Å2).
Atom | x | y | z | U 11 | U 22 | U 33 | U 23 | U 13 | U 12 |
---|---|---|---|---|---|---|---|---|---|
Cl4 | 12970.8 (10) | 8414.5 (12) | 4961.5 (6) | 0.0697 (6) | 0.0874 (7) | 0.0750 (6) | −0.0001 (4) | 0.0346 (5) | −0.0070 (4) |
O2 | 9871 (3) | 8763 (3) | 4137.4 (13) | 0.0912 (17) | 0.0686 (14) | 0.0417 (11) | 0.0135 (10) | 0.0104 (11) | −0.0056 (12) |
N4 | 8798 (3) | 7564 (2) | 4997.2 (13) | 0.0521 (12) | 0.0511 (13) | 0.0322 (11) | −0.0008 (8) | 0.0026 (9) | 0.0015 (9) |
C6 | 11470 (3) | 8030 (3) | 5393.6 (16) | 0.0620 (16) | 0.0516 (15) | 0.0391 (13) | −0.0030 (11) | 0.0137 (12) | −0.0019 (11) |
C12 | 9055 (3) | 7800 (3) | 6434.0 (16) | 0.0505 (14) | 0.0528 (14) | 0.0405 (14) | −0.0118 (11) | 0.0099 (11) | −0.0062 (11) |
C15 | 6784 (3) | 6403 (3) | 3954.4 (15) | 0.0404 (12) | 0.0621 (15) | 0.0319 (12) | 0.0046 (10) | 0.0005 (9) | 0.0099 (10) |
C17 | 8885 (3) | 6922 (3) | 5766.8 (15) | 0.0426 (12) | 0.0531 (14) | 0.0325 (12) | −0.0062 (10) | 0.0067 (9) | 0.0024 (10) |
C19 | 8737 (3) | 5441 (3) | 5841.7 (16) | 0.0563 (14) | 0.0529 (15) | 0.0382 (13) | −0.0081 (11) | 0.0060 (11) | 0.0036 (11) |
C23 | 9117 (3) | 7176 (3) | 7172.9 (17) | 0.0561 (15) | 0.0660 (17) | 0.0377 (13) | −0.0100 (12) | 0.0123 (11) | −0.0085 (13) |
C30 | 5576 (3) | 5591 (4) | 4052.0 (16) | 0.0525 (15) | 0.0726 (18) | 0.0405 (14) | 0.0116 (12) | 0.0151 (11) | 0.0060 (13) |
C32 | 8973 (3) | 5702 (4) | 7257.4 (16) | 0.0387 (12) | 0.0764 (18) | 0.0381 (13) | 0.0022 (12) | 0.0085 (10) | −0.0063 (11) |
C34 | 9989 (3) | 8150 (3) | 4779.0 (16) | 0.0676 (17) | 0.0430 (13) | 0.0376 (13) | −0.0016 (10) | 0.0100 (12) | 0.0018 (11) |
C35 | 7483 (3) | 6011 (4) | 3354.6 (18) | 0.0436 (13) | 0.0766 (19) | 0.0468 (15) | −0.0052 (14) | 0.0124 (11) | −0.0034 (12) |
C40 | 8771 (3) | 4840 (3) | 6582.9 (17) | 0.0532 (14) | 0.0553 (15) | 0.0494 (15) | 0.0026 (12) | 0.0100 (12) | −0.0013 (12) |
C41 | 7304 (3) | 7707 (3) | 4468.5 (18) | 0.0545 (16) | 0.0577 (15) | 0.0460 (15) | 0.0004 (12) | 0.0013 (12) | 0.0151 (12) |
C55 | 6977 (4) | 4840 (4) | 2867.9 (19) | 0.0620 (17) | 0.092 (2) | 0.0504 (17) | −0.0196 (16) | 0.0182 (14) | −0.0033 (16) |
C59 | 5769 (4) | 4057 (4) | 2968 (2) | 0.0608 (18) | 0.070 (2) | 0.064 (2) | −0.0146 (16) | −0.0001 (15) | −0.0042 (14) |
C62 | 9030 (5) | 5037 (5) | 8068 (2) | 0.089 (3) | 0.105 (3) | 0.0526 (19) | 0.0156 (18) | 0.0197 (17) | −0.014 (2) |
1 Source of material
Benzaldehyde (1 g, 9.42 mmol) was added to the stirred anhydrous magnesium sulfate (15 g), then dichloromethane (100 ml), finally 4-methylaniline (1.01 g, 9.42 mmol), and the reaction mixture was stirred for 6 h at room temperature. The reaction mixture was filtered and the filtrate was concentrated to obtain the crude product (E)-1-phenyl-N-(p-tolyl)methanimine, light yellow clear oil (1.77 g, yield 96.2 %). To (E)-1-phenyl-N-(p-tolyl)methanimine (1 g, 5.12 mmol) in a solution in anhydrous methanol (150 ml), we slowly added sodium borohydride (0.77 g, 20.48 mmol) for 0.5 h at low temperature, then moved to room temperature for 2 h. The solvent was steamed and dried, and a small amount of dichloromethane and dilute hydrochloric acid were added to regulate pH = 1–2. The product was washed three times with dichloromethane (30 ml), the combined organic phase, dried with anhydrous magnesium sulfate, and steamed to obtain light yellow solid (0.96 g, yield 95.02 %). 4 We added triethylamine (1.06 ml, 7.60 mmol) to a solution of N-benzyl-4-methylaniline (1 g, 5.07 mmol) in dichloromethane (100 ml), and then added chloroacetyl chloride (1.03 g, 9.12 mmol) dropwise after a 0.5 h ice salt bath. After addition, we stabilize at low temperature for 1 h. Transferred to room temperature and stirred for 9 h. Then we extracted the organic layer from a saturated salt aqueous solution and merged the organic layers. We dried with anhydrous magnesium sulfate, filtered, and evaporated the filtrate to obtain a light yellow solid (1.24 g, yield 89.36 %). The compounds were dissolved in dichloromethane/methanol. The solvent was then slowly volatilized in the air at low temperatures. A few days later, the crystals of the compound were obtained. 1 H-NMR (600 MHz, DMSO-d6) d 7.31–7.27 (m, 2H), 7.26–7.21 (m, 1H), 7.21–7.17 (m, 4H), 7.12–7.08 (m, 2H), 4.86 (s, 2H), 4.06 (s, 2H), 2.29 (s, 3H). 13 C-NMR (151 MHz, DMSO-d6) d 165.66, 138.14, 136.93, 130.07, 129.22, 128.33, 127.90 (d, J = 21.8 Hz), 52.66, 42.35, 20.57. MS(ESI):m/z = 274.0900 [M+H]+; FTIR (KBr, cm−1), 3003.12 (C–H methyl), 2933.69 (C–H methylene), 1668.40 (C=O ketone), 1508.31 (C=C benzene double bonds), 1398.37 (C–N amide bond), 752.23 (C–Cl carbon chlorine single bond).
2 Experimental details
Hydrogen atoms were placed in their geometrically idealized positions and constrained to ride on their parent atoms.
3 Comment
The amide bond is undoubtedly one of the most important structural motifs in nature. 5 , 6 Amides are not only restricted to biological systems but also undeniably present in an enormous array of molecules, along with major marketed drugs. In addition, the US FDA approved drugs like imatinib (Bcr-Abl tyrosine-kinase inhibitor), nilotinib (tyrosine-kinase inhibitor), ponatinib (multi-targeted tyrosine-kinase inhibitor), dasatinib (tyrosine-kinase inhibitor), afatinib (tyrosine kinase inhibitor), methotrexate (dihydrofolate reductase inhibitor) and carfilzomib (selective proteasome inhibitor) which are used for the treatment of different types of cancers also carry amide bond as an indispensable structural motif. 7 And the acylation of amine is one of the most widely practiced reactions in the pharmaceutical industry. 8 The crystal molecular packing of the title compound was formed by hydrogen bonds and van der Waals interactions. The hydrogen bond in the molecular structure of the target compound includes one intramolecular C41–H41A⋯O2 (2.750 Å) hydrogen bond. The above mentioned interactions play an important role in the stability of the crystal structure. Geometric parameters are all in the expected ranges. 9
-
Author contribution: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: This work was supported by the Excellent youth project of Heilongjiang Natural Science Foundation (YQ2021H027), and the project of Cultivating Young Innovative Talents in Heilongjiang Province (UNPYSCT-2020056), and National Fund Cultivation Program of Jiamusi University (JMSUGPZR2022-007).
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
References
1. Sheldrick, G. M. Shelxtl – Integrated Space-Group and Crystal-Structure Determination. Acta Crystallogr. 2015, A71, 3–8. https://doi.org/10.1107/s2053273314026370.Search in Google Scholar PubMed PubMed Central
2. Sheldrick, G. M. Crystal Structure Refinement with Shelxl. Acta Crystallogr. 2015, C71, 3–8. https://doi.org/10.1107/s2053229614024218.Search in Google Scholar PubMed PubMed Central
3. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. Olex2: A Complete Structure Solution, Refinement and Analysis Program. J. Appl. Crystallogr. 2009, 42, 339–341. https://doi.org/10.1107/s0021889808042726.Search in Google Scholar
4. Gong, Y.; Cao, X.; Zhao, M.; Xu, Y.; Geng, Y. Synthesis, Crystal Structure, and DFT Study of 4-((Furan-2-Ylmethyl)Amino)Benzoic Acid and N′-Acryloyl-N′-Phenylfuran-2-Carbohydrazide Compounds. Mol. Cryst. Liq. Cryst. 2023, 765, 54–64. https://doi.org/10.1080/15421406.2023.2213583.Search in Google Scholar
5. Pattabiraman, V. R.; Bode, J. W. Rethinking Amide Bond Synthesis. Nature 2011, 480, 471–479. https://doi.org/10.1038/nature10702.Search in Google Scholar PubMed
6. Joullié, M. M.; Lassen, K. M. Evolution of Amide Bond Formation. ARKIVOC 2010, 8, 189–250. https://doi.org/10.3998/ark.5550190.0011.816.Search in Google Scholar
7. Wu, P.; Nielsen, T. E.; Clausen, M. H. FDA-Approved Small-Molecule Kinase Inhibitors. Trends Pharmacol. Sci. 2015, 36, 422–439. https://doi.org/10.1016/j.tips.2015.04.005.Search in Google Scholar PubMed
8. Lundberg, H.; Tinnis, F.; Selander, N.; Adolfsson, H. Catalytic Amide Formation from Non-Activated Carboxylic Acids and Amines. Chem. Soc. Rev. 2014, 43, 2714–2742. https://doi.org/10.1039/c3cs60345h.Search in Google Scholar PubMed
9. Wille, G., Mayser, P., Thoma, W. Malassezin—a novel agonist of the arylhydrocarbon receptor from the yeast Malassezia furfur. Bioorg. Med. Chem. 2001, 9(4), 955–960; https://doi.org/10.1016/s0968-0896(00)00319-9.Search in Google Scholar PubMed
© 2024 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- The crystal structure of hexaquazinc(II) poly[hexakis(μ2-4-methylbenzenesulfinato-κ2O:O′) dizinc(II)]
- The crystal structure of poly[((2-(4,5-dihydro-1H-pyrazol-4-yl)-1,3-dioxoisoindoline-5-carbonyl)oxy)(1-(dimethylamino)ethoxy)zinc[II]], C16H14ZnN4O5
- Crystal structure of bis[(triaqua-4-iodopyridine-2,6-dicarboxylato-κ 3 N,O,O ″)cobalt(II)] trihydrate, C14H22N2O17I2Co2
- Crystal structure of bis(methanol-κO)-bis(nitrato-kO)-bis(1-((2-(2-chloro-4-(4-chlorophenoxy)phenyl)-4-methyl-1,3-dioxolan-2-yl)methyl)-1H-1,2,4-triazole-κN)cadmium(II), C40H42O14N8Cl4Cd
- Crystal structure of poly[μ2-dichlorido-(μ2-1-[(2,4-dimethyl-1H-triazole-1-yl)methyl]-1H-benzotriazole-κ2N:N′)cadmium(II)], C11H12CdN6Cl2
- The crystal structure of (3aS, 4R, 7S, 7aR)-hexahydro-4, 7-methano-1H-isoindole-1, 3-(2H)-dione, C9H11NO2
- The crystal structure of N-(acridin-9-yl)-4-chloro-N-(4-chloro-butanoyl) butanamide, C21H20Cl2N2O2
- Crystal structure of 3,3′-dimethoxy-4,4′-oxy-di-benzaldehyde, C16H14O5
- The crystal structure of tetrakis(μ 2-2-amino-3,5-dibromobenzoate-κ 2 O:O′)-octakis(n-butyl-κ 1 C)-bis(μ 3-oxo)tetratin(II), C60H92Br8N4O10Sn4
- Crystal structure of methyl-1-(naphthalen-1-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b] indole-3-carboxylate, C23H20N2O2
- Crystal structure of tetrapropylammonium bicarbonate–1-(diaminomethylene)thiourea(1/1)
- Crystal structure of 6,6′-((1E,1′E)-((2-phenylpyrimidine-4,6-diyl)bis(hydrazin-2-yl-1-ylidene))bis(methaneylylidene))bis(2-methoxyphenol)monohydrate, C26H26N6O5
- Crystal structure of bis(N,N,N-trimethylbutanaminium) tetrathiotungstate(VI), (BuMe3N)2[WS4]
- The crystal structure of 2,3,9-triphenyl-9-(2-phenylbenzofuran-3-yl)-9H-9λ 5-benzo[4,5][1,2]oxaphospholo[2,3-b][1,2,5]oxadiphosphole 2-oxide, C40H28O4P2
- Crystal structure of 1–methyl-3-propyl-4-nitro-1H-pyrazole-5-carboxylic acid, C8H11N3O4
- Crystal structure of N-(benzo[d]thiazol-2-yl)-2-chloroacetamide, C9H7ClN2OS
- The crystal structure of N-benzyl-2-chloro-N-(p-tolyl) acetamide, C16H16ClNO
- Crystal structure of 3,4-dimethoxybenzyl 2-(6-methoxynaphthalen-2-yl)propanoate, C23H24O5
- Crystal structure of 2,5-bis(2,5-dimethoxybenzyl)-3,6-dimethyl-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione, C26H28N2O6
- Crystal structure of poly[(μ3-5-bromoisophthalato-κ4 O,O′ :O″,O‴)-(μ2-1,2-bis(1,2,4-triazole-1-ylmethyl)benzene-κ2 N:N′)cobalt(II)], C20H15BrCoN6O4
- The crystal structure of bis(2-(piperidin-1-ium-4-yl)-1Hbenzo[d]imidazol-3-ium) dihydrogen decavanadate, C24H36N6O28V10
- Crystal structure of diaqua-bis(1-(3-carboxyphenyl)-5-methyl-4-oxo-1,4-dihydropyridazine3-carboxylato-O,O′)-cobalt(ii)dihydrate, C26H36N4O14Co
- Crystal structure of poly[(μ2-5-bromoisophthalato-κ4 O,O ′:O ″,O ‴)-(μ2-1,4-bis(2-methylimidazol-1-ylmethyl)benzene-N:N′)cadmium(II)], C24H21BrCdN4O4
- The crystal structure of dimethyl 8-(3-methoxy-2-(methoxycarbonyl)-3-oxoprop-1-en-1-yl)-4-methyl-1-(p-tolyl)-1,3a,4,8b-tetrahydro-3H-furo[3,4-b]indole-3,3-dicarboxylate. C28H29NO9
- Crystal structure of (3R)-1-(3,5-dimethoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate chloride, C21H23ClN2O4
- Synthesis and crystal structure of 3-(4,5-dihydroisoxazol-3-yl)-2-methyl-4-(methylsulfonyl)benzoic acid, C12H13NO5S
- The crystal structure of hexaaquamagnesium(II) bis-3-(1,2,3,4-tetrahydrobenzo[4,5]imidazo[1,2-α]pyridin-1-yl)benzoate, C36H42N4O10Mg
- Crystal structure of 4-formyl-2-methoxyphenyl 2-acetoxybenzoate, C17H14O6
- Crystal structure of poly[octakis(μ-oxido)-tris(μ-1,1′-[[1,1′-biphenyl]-4,4′-diylbis(methylene)]bis(1H-imidazole))-tetrakis(oxido)-tetra-vanadium-dimanganese(II)dihydrate], C30H29MnN6O7V2
- Crystal structure of 4,8a-bis(4-chlorophenyl)-1,5,6-tris(4-fluorobenzyl)-1,4,4a,4b,5,6,8a,8b-octahydrocyclobuta[1,2-b:3,4-c′]dipyridine-3,8-dicarbonitrile, C45H33Cl2F3N4
- Crystal structure of benzo[d][1,3]dioxol-5-ylmethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C22H20O5
- Crystal structure of N-benzoyl-N-phenylhydroxylaminato-dicarbonylrhodium(I), [Rh(BNA)CO2]
- The crystal structure of N-(2-((2-methoxynaphthalen-1-yl)ethynyl)phenyl)-4-methylbenzenesulfonamide, C26H21NO3S
- The crystal structure of methyl ((4-aminobenzyl)sulfonyl)-d-prolinate, C13H18N2O4S
- The crystal structure of dichlorido-(N-isopropyl-N-(pyridin-2-ylmethyl)propan-2-amine-κ 2 N, N′)palladium(II), C12H20N2PdCl2
- Crystal structure of poly[(μ 2-5-hydroxyisophthalato-κ4 O,O′:O″,O‴)-(μ 2-1,4-bis(2-methylimidazolyl)-1-butene-N:N′)nickel(II)], C20H20NiN4O5
- The crystal structure of {hexakis(1-methyl-1H-imidazole-κ 1 N)cobalt(II)}(μ 2-oxido)-hexaoxido-dimolybdenum(VI)— 1-methyl-1H-imidazole (1/2), C32H48CoMo2N16O7
- Synthesis, crystal structure and nonlinear optical property of 1-((propan-2-ylideneamino)oxy)propan-2-yl-4-methylbenzenesulfonate, C13H19O4NS
- The crystal structure of N,N-(ethane-1,1-diyl)dibenzamide, C16H16N2O2
- Crystal structure of 1-(4-bromophenyl)-3-(diphenylphosphoryl)-3-hydroxypropan-1-one, C21H18BrO3P
- The crystal structure of fac-tricarbonyl(bis(3,5-dimethyl-4H-pyrazole)-κ1 N)-((nitrato)-κ1 O)-rhenium(I)— 3,5-dimethyl-4H-pyrazole(1/1), C18H23N7O6Re
- The crystal structure of 4′-chloro-griseofulvin: (2S,6′R)-4′,7-dichloro-4,6-dimethoxy-6′-methyl-3H-spiro[benzofuran-2,1′-cyclohexan]-3′-ene-2′,3-dione, C16H14Cl2O5
- Crystal structure of tetraethylammonium bicarbonate–1-(diaminomethylene)thiourea(1/1)
- Crystal structure of 1-cyclohexyl-4-p-tolyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester, C22H27NO4
- The crystal structure of catena-poly(μ2-1,4-bis-(1H-imidazol-1-yl)benzene-copper(I)) dichloridocopper(I), {[CuC12H10N4]+[CuCl2]−} n
- The crystal structure of propane-1-aminium-2-carbamate, C4H10N2O2
- Crystal structure of 5,6,3′,4′,5′-pentamethoxy-flavone dihydrate, C20H24O9
- Crystal structure of (E)-N-(2-bromophenyl)-4-(4-(3,5-dimethoxystyryl)phenoxy)pyrimidin-2-amine, C26H22BrN3O3
- Crystal structure of methyl (3R)-1-(2-bromo-4-fluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride hydrate, C19H19BrClFN2O3
- The crystal structure of 1-(2-chlorophenyl)-3-(p-tolyl)urea, C14H13ClN2O
- The crystal structure of 1-cyclohexyl-3-(p-tolyl)urea, C14H20N2O
- Crystal structure of ((benzyl(hydroxy)-amino)(4-chlorophenyl)methyl)-diphenylphosphine oxide, C26H23ClNO2P
- The crystal structure of ethyl 3-(1-methyl-1H-indole-2-carbonyl)-2-phenylquinoline-4-carboxylate, C28H22N2O3
- The crystal structure of 1,4-bis(1H-imidazol-3-ium-1-yl)benzene dinitrate, C12H12N4 2+·2(NO3 −)
- Crystal structure of tris(hexafluoroacetylacetonato-κ2O,O′) bis(triphenylphosphine oxide-κ1O)samarium(III), C51H33F18O8P2Sm
- Crystal structure of 1-(4-(dimethylamino)phenyl)-2,3-bis(diphenylphosphoryl)propan-1-one, C35H33NO3P2
- Crystal structure of diaqua[bis(μ 2-pyridine 2,6-dicarboxylato) bismuth(III) potassium(I)], C14H10BiKN2O10
- Crystal structure of (R)-N, N ′-dimethyl-[1, 1′-binaphthalene]-2, 2′-diamine, C22H20N2
- Crystal structure of 1-phenyl-4-(2-furoyl)-3-furyl-1H-pyrazol-5-ol, C18H12N2O4
- Crystal structure of bis(14,34-dimethyl[11,21:23,31-terphenyl]-22-yl)diselane, C40H34Se2
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- The crystal structure of hexaquazinc(II) poly[hexakis(μ2-4-methylbenzenesulfinato-κ2O:O′) dizinc(II)]
- The crystal structure of poly[((2-(4,5-dihydro-1H-pyrazol-4-yl)-1,3-dioxoisoindoline-5-carbonyl)oxy)(1-(dimethylamino)ethoxy)zinc[II]], C16H14ZnN4O5
- Crystal structure of bis[(triaqua-4-iodopyridine-2,6-dicarboxylato-κ 3 N,O,O ″)cobalt(II)] trihydrate, C14H22N2O17I2Co2
- Crystal structure of bis(methanol-κO)-bis(nitrato-kO)-bis(1-((2-(2-chloro-4-(4-chlorophenoxy)phenyl)-4-methyl-1,3-dioxolan-2-yl)methyl)-1H-1,2,4-triazole-κN)cadmium(II), C40H42O14N8Cl4Cd
- Crystal structure of poly[μ2-dichlorido-(μ2-1-[(2,4-dimethyl-1H-triazole-1-yl)methyl]-1H-benzotriazole-κ2N:N′)cadmium(II)], C11H12CdN6Cl2
- The crystal structure of (3aS, 4R, 7S, 7aR)-hexahydro-4, 7-methano-1H-isoindole-1, 3-(2H)-dione, C9H11NO2
- The crystal structure of N-(acridin-9-yl)-4-chloro-N-(4-chloro-butanoyl) butanamide, C21H20Cl2N2O2
- Crystal structure of 3,3′-dimethoxy-4,4′-oxy-di-benzaldehyde, C16H14O5
- The crystal structure of tetrakis(μ 2-2-amino-3,5-dibromobenzoate-κ 2 O:O′)-octakis(n-butyl-κ 1 C)-bis(μ 3-oxo)tetratin(II), C60H92Br8N4O10Sn4
- Crystal structure of methyl-1-(naphthalen-1-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b] indole-3-carboxylate, C23H20N2O2
- Crystal structure of tetrapropylammonium bicarbonate–1-(diaminomethylene)thiourea(1/1)
- Crystal structure of 6,6′-((1E,1′E)-((2-phenylpyrimidine-4,6-diyl)bis(hydrazin-2-yl-1-ylidene))bis(methaneylylidene))bis(2-methoxyphenol)monohydrate, C26H26N6O5
- Crystal structure of bis(N,N,N-trimethylbutanaminium) tetrathiotungstate(VI), (BuMe3N)2[WS4]
- The crystal structure of 2,3,9-triphenyl-9-(2-phenylbenzofuran-3-yl)-9H-9λ 5-benzo[4,5][1,2]oxaphospholo[2,3-b][1,2,5]oxadiphosphole 2-oxide, C40H28O4P2
- Crystal structure of 1–methyl-3-propyl-4-nitro-1H-pyrazole-5-carboxylic acid, C8H11N3O4
- Crystal structure of N-(benzo[d]thiazol-2-yl)-2-chloroacetamide, C9H7ClN2OS
- The crystal structure of N-benzyl-2-chloro-N-(p-tolyl) acetamide, C16H16ClNO
- Crystal structure of 3,4-dimethoxybenzyl 2-(6-methoxynaphthalen-2-yl)propanoate, C23H24O5
- Crystal structure of 2,5-bis(2,5-dimethoxybenzyl)-3,6-dimethyl-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione, C26H28N2O6
- Crystal structure of poly[(μ3-5-bromoisophthalato-κ4 O,O′ :O″,O‴)-(μ2-1,2-bis(1,2,4-triazole-1-ylmethyl)benzene-κ2 N:N′)cobalt(II)], C20H15BrCoN6O4
- The crystal structure of bis(2-(piperidin-1-ium-4-yl)-1Hbenzo[d]imidazol-3-ium) dihydrogen decavanadate, C24H36N6O28V10
- Crystal structure of diaqua-bis(1-(3-carboxyphenyl)-5-methyl-4-oxo-1,4-dihydropyridazine3-carboxylato-O,O′)-cobalt(ii)dihydrate, C26H36N4O14Co
- Crystal structure of poly[(μ2-5-bromoisophthalato-κ4 O,O ′:O ″,O ‴)-(μ2-1,4-bis(2-methylimidazol-1-ylmethyl)benzene-N:N′)cadmium(II)], C24H21BrCdN4O4
- The crystal structure of dimethyl 8-(3-methoxy-2-(methoxycarbonyl)-3-oxoprop-1-en-1-yl)-4-methyl-1-(p-tolyl)-1,3a,4,8b-tetrahydro-3H-furo[3,4-b]indole-3,3-dicarboxylate. C28H29NO9
- Crystal structure of (3R)-1-(3,5-dimethoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate chloride, C21H23ClN2O4
- Synthesis and crystal structure of 3-(4,5-dihydroisoxazol-3-yl)-2-methyl-4-(methylsulfonyl)benzoic acid, C12H13NO5S
- The crystal structure of hexaaquamagnesium(II) bis-3-(1,2,3,4-tetrahydrobenzo[4,5]imidazo[1,2-α]pyridin-1-yl)benzoate, C36H42N4O10Mg
- Crystal structure of 4-formyl-2-methoxyphenyl 2-acetoxybenzoate, C17H14O6
- Crystal structure of poly[octakis(μ-oxido)-tris(μ-1,1′-[[1,1′-biphenyl]-4,4′-diylbis(methylene)]bis(1H-imidazole))-tetrakis(oxido)-tetra-vanadium-dimanganese(II)dihydrate], C30H29MnN6O7V2
- Crystal structure of 4,8a-bis(4-chlorophenyl)-1,5,6-tris(4-fluorobenzyl)-1,4,4a,4b,5,6,8a,8b-octahydrocyclobuta[1,2-b:3,4-c′]dipyridine-3,8-dicarbonitrile, C45H33Cl2F3N4
- Crystal structure of benzo[d][1,3]dioxol-5-ylmethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C22H20O5
- Crystal structure of N-benzoyl-N-phenylhydroxylaminato-dicarbonylrhodium(I), [Rh(BNA)CO2]
- The crystal structure of N-(2-((2-methoxynaphthalen-1-yl)ethynyl)phenyl)-4-methylbenzenesulfonamide, C26H21NO3S
- The crystal structure of methyl ((4-aminobenzyl)sulfonyl)-d-prolinate, C13H18N2O4S
- The crystal structure of dichlorido-(N-isopropyl-N-(pyridin-2-ylmethyl)propan-2-amine-κ 2 N, N′)palladium(II), C12H20N2PdCl2
- Crystal structure of poly[(μ 2-5-hydroxyisophthalato-κ4 O,O′:O″,O‴)-(μ 2-1,4-bis(2-methylimidazolyl)-1-butene-N:N′)nickel(II)], C20H20NiN4O5
- The crystal structure of {hexakis(1-methyl-1H-imidazole-κ 1 N)cobalt(II)}(μ 2-oxido)-hexaoxido-dimolybdenum(VI)— 1-methyl-1H-imidazole (1/2), C32H48CoMo2N16O7
- Synthesis, crystal structure and nonlinear optical property of 1-((propan-2-ylideneamino)oxy)propan-2-yl-4-methylbenzenesulfonate, C13H19O4NS
- The crystal structure of N,N-(ethane-1,1-diyl)dibenzamide, C16H16N2O2
- Crystal structure of 1-(4-bromophenyl)-3-(diphenylphosphoryl)-3-hydroxypropan-1-one, C21H18BrO3P
- The crystal structure of fac-tricarbonyl(bis(3,5-dimethyl-4H-pyrazole)-κ1 N)-((nitrato)-κ1 O)-rhenium(I)— 3,5-dimethyl-4H-pyrazole(1/1), C18H23N7O6Re
- The crystal structure of 4′-chloro-griseofulvin: (2S,6′R)-4′,7-dichloro-4,6-dimethoxy-6′-methyl-3H-spiro[benzofuran-2,1′-cyclohexan]-3′-ene-2′,3-dione, C16H14Cl2O5
- Crystal structure of tetraethylammonium bicarbonate–1-(diaminomethylene)thiourea(1/1)
- Crystal structure of 1-cyclohexyl-4-p-tolyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester, C22H27NO4
- The crystal structure of catena-poly(μ2-1,4-bis-(1H-imidazol-1-yl)benzene-copper(I)) dichloridocopper(I), {[CuC12H10N4]+[CuCl2]−} n
- The crystal structure of propane-1-aminium-2-carbamate, C4H10N2O2
- Crystal structure of 5,6,3′,4′,5′-pentamethoxy-flavone dihydrate, C20H24O9
- Crystal structure of (E)-N-(2-bromophenyl)-4-(4-(3,5-dimethoxystyryl)phenoxy)pyrimidin-2-amine, C26H22BrN3O3
- Crystal structure of methyl (3R)-1-(2-bromo-4-fluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride hydrate, C19H19BrClFN2O3
- The crystal structure of 1-(2-chlorophenyl)-3-(p-tolyl)urea, C14H13ClN2O
- The crystal structure of 1-cyclohexyl-3-(p-tolyl)urea, C14H20N2O
- Crystal structure of ((benzyl(hydroxy)-amino)(4-chlorophenyl)methyl)-diphenylphosphine oxide, C26H23ClNO2P
- The crystal structure of ethyl 3-(1-methyl-1H-indole-2-carbonyl)-2-phenylquinoline-4-carboxylate, C28H22N2O3
- The crystal structure of 1,4-bis(1H-imidazol-3-ium-1-yl)benzene dinitrate, C12H12N4 2+·2(NO3 −)
- Crystal structure of tris(hexafluoroacetylacetonato-κ2O,O′) bis(triphenylphosphine oxide-κ1O)samarium(III), C51H33F18O8P2Sm
- Crystal structure of 1-(4-(dimethylamino)phenyl)-2,3-bis(diphenylphosphoryl)propan-1-one, C35H33NO3P2
- Crystal structure of diaqua[bis(μ 2-pyridine 2,6-dicarboxylato) bismuth(III) potassium(I)], C14H10BiKN2O10
- Crystal structure of (R)-N, N ′-dimethyl-[1, 1′-binaphthalene]-2, 2′-diamine, C22H20N2
- Crystal structure of 1-phenyl-4-(2-furoyl)-3-furyl-1H-pyrazol-5-ol, C18H12N2O4
- Crystal structure of bis(14,34-dimethyl[11,21:23,31-terphenyl]-22-yl)diselane, C40H34Se2